Clinical report on the L95P mutation in a Dutch family with paraganglioma

Otology and Neurotology

Volumn 23, Issue 5, 2002, Pages 755-759

  Cremers, C W R J ^a   De Monnink J P ^a   Arts, N ^a   Joosten, F B M ^a   Kremer, H ^a   Hoefsloot, L ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autosomal dominant; Genomic imprinting; Glomus tumors; Nonchromaffenic paraganglioma; Paraganglioma 1 gene; Succinate ubiquinone oxidoreductase subunit gene

Indexed keywords

SUCCINATE DEHYDROGENASE (UBIQUINONE);

ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CAROTID BODY TUMOR; CHEMODECTOMA; CLINICAL ARTICLE; FAMILIAL DISEASE; FEMALE; FOLLOW UP; GENE MUTATION; GENOME IMPRINTING; GLOMUS TUMOR; HUMAN; MALE; MUTATIONAL ANALYSIS; NETHERLANDS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARAGANGLIOMA; PEDIGREE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

EID: 0036734773     PISSN: 15317129     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129492-200209000-00024     Document Type: Article

References (19)

1. Heutink P, Van der Mey AG, Sandkuijl LA, et al. A gene study to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet 1992;1:7-10.
2. Mariman EC, Van Beersum SE, Cremers CWRJ, et al. Analysis of a second family with hereditary non-chromaffin paragangliomas locates the underlying gene at the proximal region of chromosome 11q. Hum Genet 1993;91:357-61.
3. Niemann S, Muller U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat Genet 2000;26:268-70.
4. Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex 11 gene, in hereditary paraganglioma. Science 2000;287:848-51.
5. Van Baars FM, Dohmen J, Van den Broek P, et al. Glomus tumoren. Ned Ts Geneesk 1975;119:1839-47.
6. Hermann J. Delayed mutation model: carotid tumors and retinoblastoma. In: Genetics in human cancer. Mew York: Raven Press, 1977.
7. Van der Mey AG, Maaswinkel-Mooy PD, Cornelisse CJ. Genomic imprinting in hereditary glomus tumours: evidence for new genetic theory [review] [see comments]. Lancet 1989;2:1291-4.
8. Struycken PM, Cremers CWRJ, Mariman ECM, et al. Glomus tumors and genomic imprinting: influence of inheritance along the paternal or maternal line. Clin Otolaryngol 1997;22:71-6.
9. Niemann S, Steinberger D, Muller U. PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma. Neurogenetics 1999;2:167-70.
10. Van Baars FM, Cremers CWRJ, Van den Broek P, et al. Familial non-chromaffenic paragangliomas (glomus tumors): clinical and genetic aspects (abridged). Acta Otolaryngol (Stockh) 1981;91:589-93.
11. Van Baars FM, Cremers CWRJ, Van den Broek P, et al. Familial glomus tumors: clinical and genetic aspects. Acta Otorhinolaryngol Belg 1981;35:50-5.
12. Van Baars F, Cremers C, Van den Broek P, et al. Genetic aspects of nonchromaffenic paraganglioma. Hum Genet 1982;60:305-9.
13. Mariman EC, Van Beersum SE, Cremers CWRJ, et al. Fine mapping of a putatively imprinted gene for familial non-chromaffin paragangliomas to chromosome 11q13.1: evidence for genetic heterogeneity. Hum Genet 1995;95:56-62.
14. Taschner P, Jansen PC, Baysal BE, et al. Nearly all hereditary paragangliomas in the Netherlands are caused by two founder mutations in the SDHD gene. Genes, Chromosomes, & Cancer 2001;31:274-81.
15. Van Schothorst EM, Jansen JC, Grooters E, et al. Founder effect at PGL1 in hereditary head and neck paraganglioma families from the Netherlands. Am J Hum Genet 1998;63:468-73.
16. Jansen JC, Van den Berg R, Kuiper A, et al. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer 2000;88:2811-6.
17. Lundin P, Pedersen F. Volume of pituitary macroadenomas: assessment by MRI. J Comput Assist Tomogr 1992;16:519-28.
18. Jansen JC, Oosterwijk JC, Van Schothorst EM, et al. The risk of head and neck paragangliomas in SDHD mutation carriers. Chapter 7 in Ph.D. thesis.
19. Deleted in proof.